0000899243-19-010033.txt : 20190404 0000899243-19-010033.hdr.sgml : 20190404 20190404183707 ACCESSION NUMBER: 0000899243-19-010033 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190402 FILED AS OF DATE: 20190404 DATE AS OF CHANGE: 20190404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Singhal Priya CENTRAL INDEX KEY: 0001769608 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36510 FILM NUMBER: 19733183 MAIL ADDRESS: STREET 1: C/O ZAFGEN, INC. STREET 2: 175 PORTLAND STREET 4TH FL CITY: BOSTON STATE: MA ZIP: 02114 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZAFGEN, INC. CENTRAL INDEX KEY: 0001374690 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203857670 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 175 PORTLAND STREET STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02114 BUSINESS PHONE: 617-622-4003 MAIL ADDRESS: STREET 1: 175 PORTLAND STREET STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02114 FORMER COMPANY: FORMER CONFORMED NAME: ZAFGEN INC DATE OF NAME CHANGE: 20060906 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-04-02 0 0001374690 ZAFGEN, INC. ZFGN 0001769608 Singhal Priya C/O ZAFGEN, INC., 4TH FLOOR 175 PORTLAND STREET BOSTON MA 02114 0 1 0 0 Head of Research & Development Stock Option (Right to Buy) 2.89 2019-04-02 4 A 0 375000 0.00 A 2029-03-03 Common Stock 375000 375000 D 25% of this option vests on March 4, 2020, and the remainder vests in equal monthly installments thereafter over 36 months. The option has been granted pursuant to an inducement award agreement outside of the company's 2014 Stock Option and Incentive Plan as a material inducement to the reporting person's acceptance of employment with the company in accordance with NASDAQ Listing Rule 5635(c)(4). The option is subject to acceleration upon a change in control. /s/ Shoaib Ghias, Attorney-In-Fact 2019-04-04